Citation
Irlam J, West CML. Time to Rethink Commercialisation: Spin out or Lose out? Clin Oncol (R Coll Radiol). 2022.Journal
Clinical OncologyDOI
10.1016/j.clon.2022.03.007PubMed ID
35346561Additional Links
https://dx.doi.org/10.1016/j.clon.2022.03.007Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2022.03.007
Scopus Count
Collections
Related articles
- Identifying the nature and extent of public and donor concern about the commercialisation of biobanks for genomic research.
- Authors: Critchley CR, Fleming J, Nicol D, Marlton P, Ellis M, Devereux L, Bruce G, Kerridge I
- Issue date: 2021 Mar
- It's time to lose the logroll. We need to rethink our first-line patient movement techniques.
- Authors: Smith M
- Issue date: 2010 May
- A Semi-Serendipitous Journey towards the Commercialisation of a Catalytic Hydrocracking Process for Polymer Waste.
- Authors: Bobbink FD, van Muyden A, Lee WT, Dyson PJ
- Issue date: 2022 Apr
- Commercialisation and commodification of breastfeeding: video diaries by first-time mothers.
- Authors: Taylor AM, Alexander J, van Teijlingen E, Ryan KM
- Issue date: 2020 May 1
- Preventing mental illness in children that experienced maltreatment the efficacy of REThink online therapeutic game.
- Authors: David OA, Fodor LA
- Issue date: 2023 Jun 5